As a tumour suppressor, TP53 has a high mutation frequency among various kinds of tumours, and the mutant form is equipped with antiproliferative functions and is related to the metastasis and progression of prostate cancer [13, 14]. This evidence concerns the gene TP53 and prostate carcinoma.